The US generic injectables market reached a value of US$ 11.7 Billion in 2018. Generic injectables refer to bioequivalents of branded drugs that are not protected by patents. They are used for rapidly transporting the drug into the body, bypassing the first-pass metabolism. Since they have a similar quality, dosage, strength, effect and active ingredient, generic injectables are as safe and effective as innovator injectables. They are widely used in the United States on account of the rise in the prevalence of lifestyle ailments due to sedentary lifestyles, non-nutritive diet and aging population. They are utilized in the treatment of diseases such as cancer, diabetes, osteoporosis, osteoarthritis, rheumatoid arthritis, respiratory and cardiovascular disorders.
The US is witnessing a rise in the demand for generic injectables on account of increasing investment by the US Government for the development of generic drugs. It is focusing on promoting generic injectables to reduce healthcare expenditure in the country. Further, drug shortages in confluence with speedy approvals by the USFDA are expected to boost the manufacturing of these drugs. Moreover, several branded injectables firms are also anticipated to lose their patient protection in the upcoming years, thereby offering numerous remunerative opportunities to the generic injectables manufacturers. According to IMARC Group’s estimates, the market is further projected to reach US$ 18.3 Billion by 2024, exhibiting a CAGR of 7.5% during the forecast period (2019-2024).
Breakup by Therapeutic Area:
- Oncology
- Anesthesia
- Anti-Infectives
- Parenteral Nutrition
- Cardiovascular Diseases
The report finds that the oncology segment exhibits dominance in the market as injectables are used to treat different types of cancers. It is followed by anti-infectives, cardiovascular, parenteral nutrition and anesthesia.
Breakup by Containers:
- Vials
- Ampoules
- Premix
- Prefilled Syringes
Currently, vials account for the majority of the total market share as they are flexible, easy to dispose of and cost-effective. They are followed by premix, prefilled syringes and ampoules.
Breakup by Distribution Channel:
- Hospitals
- Retail Pharmacy
At present, hospitals represent the largest segment as the injectables for oncology, anesthesia, and anti-infectives cannot be administrated without medical assistance.
Competitive Landscape:
The market is highly concentrated in nature with the presence of only a few top manufacturers who compete against one another in terms of prices and quality.
Key Questions Answered in this Report:
- How has the US generic injectables market performed so far and how will it perform in the coming years?
- What are the major therapeutic areas in the US generic injectables industry?
- What are the several containers used in the US generic injectables industry?
- What are the major distribution channels in the US generic injectables industry?
- What are the various stages in the value chain of the US generic injectables industry?
- What are the key driving factors and challenges in the US generic injectables industry?
- What is the structure of the US generic injectables industry and who are the key players?
- What is the degree of competition in the US generic injectables industry?
- What are the profit margins in the US generic injectables industry?
- What are the key requirements for setting up generic injectables manufacturing plant?
- How are generic injectables manufactured?
- What are the various unit operations involved in generic injectables manufacturing plant?
- What is the total size of land required for setting up generic injectables manufacturing plant?
- What are the machinery requirements for setting up generic injectables manufacturing plant?
- What are the raw material requirements for setting up generic injectables manufacturing plant?
- What are the packaging requirements for generic injectables?
- What are the transportation requirements for generic injectables?
- What is the time required to break-even?
1 Preface
2 Scope and Methodology
2.1 Objectives of the study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Generic Drug Industry
5.1 Market Overview
5.2 Market Performance
5.2.1 Sales Volume
5.2.2 Sales Value
5.3 Market Breakup by Country
5.4 Market Forecast
6 US Generic Drug Industry
6.1 Market Overview
6.2 Market Performance
6.2.1 Sales Volume
6.2.2 Sales Value
6.3 Market Forecast
7 US Generic Drug Industry – Drug Delivery Systems
7.1 Orals
7.2 Injectables
7.3 Dermal/Topical
7.4 Inhalers
8 Global Generic Injectables Industry
8.1 Market Overview
8.2 Market Performance
8.3 Market Breakup by Region
8.4 Market Breakup by Therapeutic Area
8.5 Market Breakup by Containers
8.6 Market Breakup by Distribution Channel
8.7 Market Share of Key Players
8.8 Market Forecast
9 US Generic Injectables Industry
9.1 Market Overview
9.2 Market Performance
9.3 Market by Therapeutic Area
9.4 Market by Containers
9.5 Market by Distribution Channel
9.6 Market Share of Key Players
9.7 Market Forecast
9.8 SWOT Analysis
9.8.1 Overview
9.8.2 Strength
9.8.3 Weakness
9.8.4 Opportunity
9.8.5 Threat
9.9 Value Chain Analysis
9.10 Porters Five Forces Analysis
9.10.1 Overview
9.10.2 Bargaining Power of Buyers
9.10.3 Bargaining Power of Suppliers
9.10.4 Degree of Rivalry
9.10.5 Threat of New Entrants
9.10.6 Threat of Substitutes
9.11 Key Success and Risk Factors
10 US Generic Injectable Market: Breakup by Therapeutic Area
10.1 Oncology
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Anaesthesia
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Anti-infectives
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Parenteral Nutrition
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Cardiovascular
10.5.1 Market Trends
10.5.2 Market Forecast
11 US Generic Injectable Market: Breakup by Containers
11.1 Vials
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Ampoules
11.2.1 Market Trends
11.2.2 Market Forecast
11.3 Premix
11.3.1 Market Trends
11.3.2 Market Forecast
11.4 Prefilled Syringes
11.4.1 Market Trends
11.4.2 Market Forecast
12 US Generic Injectable Market: Breakup by Distribution Channel
12.1 Hospitals
12.1.1 Market Trends
12.1.2 Market Forecast
12.2 Retail Pharmacy
12.2.1 Market Trends
12.2.2 Market Forecast
13 US Generic Injectable Market: Competitive Landscape
13.1 Competitive Structure
13.2 Market Breakup by Key Players
14 Generic Injectables Manufacturing Process
14.1 Product Overview
14.2 Detailed Process Flow
14.3 Various Types of Unit Operations Involved
14.4 Mass Balance and Raw Material Requirements
15 Project Details, Requirements and Costs Involved
15.1 Land, Location and Site Development
15.2 Construction Requirements
15.3 Machinery Requirements
15.4 Machinery Pictures
15.5 Raw Materials Requirements
15.6 Raw Material and Final Product Pictures
15.7 Packaging Requirements
15.8 Transportation Requirements
15.9 Product Pricing and Margins Across Various Levels of the Supply Chain
16 Key Players Profiles
List of Figures
Figure 1: Global: Generic Drug Market: Sales Volume Trends (in Billion Standard Units), 2011-2018
Figure 2: Global: Generic Drug Market: Sales Value Trends (in Billion US$), 2011-2018
Figure 3: Global: Generic Drug Market: Sales Value Breakup by Country (in %), 2018
Figure 4: Global: Generic Drug Market: Sales Volume Breakup by Country (in %), 2018
Figure 5: Global: Generic Drug Market Forecast: Sales Volume Trends (in Billion Standard Units), 2019-2024
Figure 6: Global: Generic Drug Market Forecast: Sales Value Trends (in Billion US$), 2019-2024
Figure 7: US: Generic Drug Market: Sales Volume Trends (in Billion Standard Units), 2011-2018
Figure 8: US: Generic Drug Market: Sales Value Trends (in Billion US$), 2011-2018
Figure 9: US: Generic Drug Market Forecast: Sales Volume Trends (in Billion Standard Units), 2019-2024
Figure 10: US: Generic Drug Market Forecast: Sales Value Trends (in Billion US$), 2019-2024
Figure 11: Global: Generic Drug Market: Drug Delivery System (in %), 2018
Figure 12: Global: Generic Injectables Market: Sales Value Trends (in Billion US$), 2011-2018
Figure 13: Global: Generic Injectables Market: Breakup by Region (in %), 2018
Figure 14: Global: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2018
Figure 15: Global: Generic Injectables Market: Breakup by Containers (in %), 2018
Figure 16: Global: Generic Injectables Market: Breakup by Distribution Channels (in %), 2018
Figure 17: Global: Generic Injectables Market: Share of Key Players (in %), 2017
Figure 18: Global: Generic Injectables Market Forecast: Sales Value Trends (in Billion US$), 2019-2024
Figure 19: US: Generic Injectables Market: Sales Value Trends (in Billion US$), 2011-2018
Figure 20: US: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2018
Figure 21: US: Generic Injectables Market: Breakup by Container (in %), 2018
Figure 22: US: Generic Injectables Market: Breakup by Distribution Channels (in %), 2018
Figure 23: US: Generic Injectables Market: Breakup by Key Players (in %), 2017
Figure 24: US: Generic Injectables Market Forecast: Sales Value Trends (in Billion US$), 2019-2024
Figure 25: US: Generic Injectables Industry: SWOT Analysis
Figure 26: US: Generic Injectables Industry: Value Chain Analysis
Figure 27: US: Generic Injectables Industry: Porter’s Five Forces Analysis
Figure 28: US: Generic Injectable (Oncology) Market: Value Trends (in Million US$), 2011 & 2018
Figure 29: US: Generic Injectable (Oncology) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 30: US: Generic Injectable (Anaesthesia) Market: Value Trends (in Million US$), 2011 & 2018
Figure 31: US: Generic Injectable (Anaesthesia) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 32: US: Generic Injectable (Anti-infectives) Market: Value Trends (in Million US$), 2011 & 2018
Figure 33: US: Generic Injectable (Anti-infectives) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 34: US: Generic Injectable (Parenteral Nutrition) Market: Value Trends (in Million US$), 2011 & 2018
Figure 35: US: Generic Injectable (Parenteral Nutrition) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 36: US: Generic Injectable (Cardiovascular) Market: Value Trends (in Million US$), 2011 & 2018
Figure 37: US: Generic Injectable (Cardiovascular) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 38: US: Generic Injectable (Vials) Market: Value Trends (in Million US$), 2011 & 2018
Figure 39: US: Generic Injectable (Vials) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 40: US: Generic Injectable (Ampoules) Market: Value Trends (in Million US$), 2011 & 2018
Figure 41: US: Generic Injectable (Ampoules) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 42: US: Generic Injectable (Premix) Market: Value Trends (in Million US$), 2011 & 2018
Figure 43: US: Generic Injectable (Premix) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 44: US: Generic Injectable (Prefilled Syringes) Market: Value Trends (in Million US$), 2011 & 2018
Figure 45: US: Generic Injectable (Prefilled Syringes) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 46: US: Generic Injectable Market: Sales through Hospitals (in Million US$), 2011 & 2018
Figure 47: US: Generic Injectable Market Forecast: Sales through Hospitals (in Million US$), 2019-2024
Figure 48: US: Generic Injectable Market: Sales through Retail Pharmacy (in Million US$), 2011 & 2018
Figure 49: US: Generic Injectable Market Forecast: Sales through Retail Pharmacy (in Million US$), 2019-2024
Figure 50: Generic Injectable Manufacturing: Detailed Process Flow
Figure 51: Generic Injectable Manufacturing Process: Conversion Rate of Feedstock
Figure 52: Generic Injectable Manufacturing: Production Cost Breakup (in %)
Figure 53: Generic Injectable Manufacturing: Profit Margins at Various Levels of the Supply Chain
List of Tables
Table 1: Global: Generic Drug Market: Key Industry Highlights, 2018 and 2024
Table 2: US: Generic Drug Market: Key Industry Highlights, 2018 and 2024
Table 3: Global: Generic Injectables Market: Key Industry Highlights, 2018 and 2024
Table 4: US: Generic Injectables Market: Key Industry Highlights, 2018 and 2024
Table 5: US: Generic Injectables Market Forecast: Breakup by Therapeutic Area (in Million US$), 2019-2024
Table 6: US: Generic Injectables Market Forecast: Breakup by Containers (in Million US$), 2019-2024
Table 7: US: Generic Injectables Market Forecast: Breakup by Distribution Channel (in Million US$), 2019-2024
Table 8: US: Generic Injectables Market: Competitive Structure
Table 9: US: Generic Injectables Market: Key Players
Table 10: Generic Injectable Manufacturing Plant: Costs Related to Land and Site Development
Table 11: Generic Injectable Manufacturing Plant: Costs Related to Civil Works
Table 12: Generic Injectable Manufacturing Plant: Costs Related to Machinery Unit
Table 13: Generic Injectable Manufacturing Plant: Raw Material Requirements
Table 14: US: Generic Injectables Market: Competitive Structure
Table 15: US: Generic Injectables Market: Key Players